Skip to main content

Table 4 One-year clinical outcomes after TAVR of propensity matched patients with CAD as well as of patients with and without periprocedural PCI separately

From: Impact of extent of coronary artery disease and percutaneous revascularization assessed by the SYNTAX score on outcomes following transcatheter aortic valve replacement

 

Patients with CAD (n = 204)

TAVR + PCI (n = 102)

Isolated TAVR (n = 102)

P value

SYNTAX score residual

7.1 ± 7.0

6.0 ± 6.5

9.1 ± 7.9

0.02

One-year mortality

19 (9.3)

5 (4.9)

14 (13.7)

0.03

30-day mortality

5 (2.5)

2 (2.0)

3 (2.9)

0.65

MACCE

43 (21.1)

17 (16.7)

26 (25.5)

0.12

Myocardial infarction

6 (2.9)

3 (2.9)

3 (2.9)

1.00

TLR

9 (4.4)

7 (6.9)

2 (2.0)

0.08

Stroke

3 (1.5)

1 (0.9)

2 (2.0)

0.56

Cardiac decompensation

6 (2.9)

1 (0.9)

5 (4.9)

0.08

  1. Data are presented as counts (%). P-values set in boldface indicate statistical significance. CAD coronary artery disease; MACCE major adverse cardiac and cerebrovascular events; PCI percutaneous coronary intervention; TAVR transcatheter aortic valve replacement; TLR target lesion revascularization